TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
7.56
-0.49 (-6.09%)
At close: Jan 31, 2025, 4:00 PM
7.55
-0.01 (-0.13%)
After-hours: Jan 31, 2025, 7:59 PM EST
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $5.26 million as of January 31, 2025. Its market cap has increased by 288.39% in one year.
Market Cap
5.26M
Enterprise Value
3.54M
1-Year Change
288.39%
Ranking
Category
Stock Price
$7.56
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $5.26M, a decrease of -89.00%. That is a compound annual growth rate of -46.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 5.26M | 124.33% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -52.59% |
| Dec 30, 2022 | 8.72M | -73.34% |
| Dec 31, 2021 | 32.72M | -31.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.32B |
| UnitedHealth Group | 499.25B |
| Novo Nordisk | 375.61B |
| Johnson & Johnson | 366.32B |
| AbbVie | 324.98B |
| Merck & Co. | 249.98B |
| Thermo Fisher Scientific | 228.64B |
| Abbott Laboratories | 221.89B |